Glaucoma, a multifactorial ocular neuropathy, can lead to irreversible vision loss. Diagnosis involves assessing optic cupping (increased cup-to-disc ratios) and structural changes (like retinal nerve fiber layer thinning) through clinical imaging. Elevated intraocular pressure (IOP) is commonly associated with glaucoma but is not universally present. However, understanding disease progression is hindered by limited access to donor ocular tissue and consistent clinical data. We hypothesized that the proteomes of aqueous humor (AH) and plasma may be altered in disease and correlate with clinical parameters such as IOP and cup-to-disc ratios.
Methods:
AH and plasma samples were collected from 36 glaucoma patients (17 male, 19 female) and 35 nonglaucomatous control patients (16 male, 19 female) undergoing cataract surgery. Protein profiles was compared using the SOMAscan® assay system for proteome profiling. From glaucomatous donors, correlations between IOP and cup-to-disc ratios to proteome differences were determined.
Results:
Overall proteomics profiles between both AH and plasma were compared by combining all samples (glaucoma and nonglaucoma) and then performing correlation analyses. This study revealed similar protein abundance in the two biological fluids. Additionally, it identified different abundance of proteins in plasma and AH between glaucoma and nonglaucoma samples. The differential proteins identified were involved in pathways related to vascular integrity, inflammation, immune response, cell adhesion, and complement activation. Generally, glaucomatous AH showed higher protein levels. Neurofilament light chain protein correlated with elevated IOP and inflammatory markers but not with cup-to-disc ratio.
Conclusions:
Together, our data demonstrate that the proteins identified in this study from glaucomatous donors correspond to markers of neurodegeneration and those that may inhibit cell proliferation or disrupt vascular integrity.
ThamY-C, LiX, WongTY, et al.Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Ophthalmology2014;121(11):2081–2090; doi: 10.1016/j.ophtha.2014.05.013
2.
AllisonK, PatelD, AlabiO. Epidemiology of glaucoma: The past, present, and predictions for the future. Cureus2020;12(11):e11686; doi: 10.7759/cureus.11686
3.
Glaucoma. In: Moorfields Manual of Ophthalmology. (JacksonTL. ed.) Mosby: Edinburgh; 2008; pp. 274–330.
4.
FreddoTF. A contemporary concept of the blood-aqueous barrier. Prog Retin Eye Res2013;32:181–195; doi: 10.1016/j.preteyeres.2012.10.004
5.
FreddoTF, JohnsonM. Chapter 6 aqueous humor outflow resistance. In: The Eye’s Aqueous Humor. Elsevier; 2008; pp. 161–192.
6.
TorisCB, YablonskiME, WangY-L, et al.Aqueous humor dynamics in the aging human eye. Am J Ophthalmol1999;127(4):407–412.
7.
TorisCB, KoepsellSA, YablonskiME, et al.Aqueous humor dynamics in ocular hypertensive patients. J Glaucoma2002;11(3):253–258.
8.
StamerWD, AcottTS. Current understanding of conventional outflow dysfunction in glaucoma. Curr Opin Ophthalmol2012;23(2):135–143; doi: 10.1097/ICU.0b013e32834ff23e
9.
AcottTS, KelleyMJ. Extracellular matrix in the trabecular meshwork. Exp Eye Res2008;86(4):543–561; doi: 10.1016/j.exer.2008.01.013
10.
VrankaJA, KelleyMJ, AcottTS, et al.Extracellular matrix in the trabecular meshwork: Intraocular pressure regulation and dysregulation in glaucoma. Exp Eye Res2015;133:112–125; doi: 10.1016/j.exer.2014.07.014
11.
YorioT, PrasannaG, Coca-PradosM. CHAPTER 4 - The ciliary body: a potential multifaceted functional neuroendocrine unit. In: Ocular Therapeutics. (YorioT, ClarkAF, WaxMB. eds.) Academic Press: London; 2008; pp. 69–85.
12.
AhmadMT, ZhangP, DufresneC, et al.The human eye proteome project: Updates on an emerging proteome. Proteomics2018;18(5–6):e1700394; doi: 10.1002/pmic.201700394
13.
BaekJ-H, LimD, ParkKH, et al.Quantitative proteomic analysis of aqueous humor from patients with drusen and reticular pseudodrusen in age-related macular degeneration. BMC Ophthalmol2018;18(1):289; doi: 10.1186/s12886-018-0941-9
14.
AghamollaeiH, ParvinS, ShahriaryA. Review of proteomics approach to eye diseases affecting the anterior segment. J Proteomics2020;225:103881; doi: 10.1016/j.jprot.2020.103881
15.
SkeieJM, RoybalCN, MahajanVB. Proteomic Insight into the molecular function of the vitreous. PLoS One2015;10(5):e0127567; doi: 10.1371/journal.pone.0127567
16.
KangGY, BangJY, ChoiAJ, et al.Exosomal proteins in the aqueous humor as novel biomarkers in patients with neovascular age-related macular degeneration. J Proteome Res2014;13(2):581–595; doi: 10.1021/pr400751k
17.
DammeierS, MartusP, KloseF, et al.Combined targeted analysis of metabolites and proteins in tear fluid with regard to clinical applications. Transl Vis Sci Technol2018;7(6):22; doi: 10.1167/tvst.7.6.22
18.
De Almeida BorgesD, AlborghettiMR, Franco Paes LemeA, et al.Tear proteomic profile in three distinct ocular surface diseases: Keratoconus, pterygium, and dry eye related to graft-versus-host disease. Clin Proteomics2020;17(1):42; doi: 10.1186/s12014-020-09307-5
19.
AgnifiliL, PieragostinoD, MastropasquaA, et al.Molecular biomarkers in primary open-angle glaucoma: From noninvasive to invasive. Prog Brain Res2015;221:1–32; doi: 10.1016/bs.pbr.2015.05.006
20.
BabizhayevMA. Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: Challenges of dual combination therapy with N-acetylcarnosine lubricant eye drops and oral formulation of nonhydrolyzed carnosine. Fundam Clin Pharmacol2012;26(1):86–117; doi: 10.1111/j.1472-8206.2011.00969.x
21.
BollingerKE, CrabbJS, YuanX, et al.Quantitative proteomics: TGFbeta(2) signaling in trabecular meshwork cells. Invest Ophthalmol Vis Sci2011;52(11):8287–8294; doi: 10.1167/iovs.11-8218
22.
Burgos-BlascoB, Vidal-VillegasB, Saenz-FrancesF, et al.Tear and aqueous humour cytokine profile in primary open-angle glaucoma. Acta Ophthalmol2020;98(6):e768–e772; doi: 10.1111/aos.14374
23.
CastanyM, JordiI, CatalaJ, et al.Glaucoma patients present increased levels of diadenosine tetraphosphate, Ap4A, in the aqueous humour. Exp Eye Res2011;92(3):221–226; doi: 10.1016/j.exer.2010.12.004
24.
CsőszÉ, DeákE, TóthN, et al.Comparative analysis of cytokine profiles of glaucomatous tears and aqueous humour reveals potential biomarkers for trabeculectomy complications. FEBS Open Bio2019;9(5):1020–1028; doi: 10.1002/2211-5463.12637
25.
GarwegJG, ZandiS, PfisterIB, et al.Comparison of cytokine profiles in the aqueous humor of eyes with pseudoexfoliation syndrome and glaucoma. PLoS One2017;12(8):e0182571; doi: 10.1371/journal.pone.0182571
26.
GuoT, GuoL, FanY, et al.Aqueous humor levels of TGFbeta2 and SFRP1 in different types of glaucoma. BMC Ophthalmol2019;19(1):170; doi: 10.1186/s12886-019-1183-1
27.
IgarashiN, HonjoM, AsaokaR, et al.Aqueous autotaxin and TGF-betas are promising diagnostic biomarkers for distinguishing open-angle glaucoma subtypes. Sci Rep2021;11(1):1408; doi: 10.1038/s41598-021-81048-3
28.
LinJB, SheybaniA, SantefordA, et al.Increased aqueous humor GDF15 is associated with worse visual field loss in pseudoexfoliative glaucoma patients. Transl Vis Sci Technol2020;9(10):16; doi: 10.1167/tvst.9.10.16
29.
SunC, ZhangH, JiangJ, et al.Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy. Int Ophthalmol2020;40(2):467–475; doi: 10.1007/s10792-019-01207-4
30.
KaeslinMA, KillerHE, FuhrerCA, et al.Changes to the aqueous humor proteome during glaucoma. PLoS One2016;11(10):e0165314; doi: 10.1371/journal.pone.0165314
31.
KaurI, KaurJ, SoorajK, et al.Comparative evaluation of the aqueous humor proteome of primary angle closure and primary open angle glaucomas and age-related cataract eyes. Int Ophthalmol2019;39(1):69–104; doi: 10.1007/s10792-017-0791-0
32.
SharmaS, BollingerKE, KodeboyinaSK, et al.Proteomic alterations in aqueous humor from patients with primary open angle glaucoma. Invest Ophthalmol Vis Sci2018;59(6):2635–2643; doi: 10.1167/iovs.17-23434
33.
Rejas-GonzálezR, Montero-CalleA, Pastora SalvadorN, et al.Unraveling the nexus of oxidative stress, ocular diseases, and small extracellular vesicles to identify novel glaucoma biomarkers through in-depth proteomics. Redox Biol2024;77:103368; doi: 10.1016/j.redox.2024.103368
34.
SaccàSC, CentofantiM, IzzottiA. New proteins as vascular biomarkers in primary open angle glaucomatous aqueous humor. Invest Ophthalmol Vis Sci2012;53(7):4242–4253; doi: 10.1167/iovs.11-8902
35.
BeutgenVM, GraumannJ. Advances in aqueous humor proteomics for biomarker discovery and disease mechanisms exploration: A spotlight on primary open angle glaucoma. Front Mol Neurosci2024;17:1397461; doi: 10.3389/fnmol.2024.1397461
36.
AdavSS, WeiJ, TerenceY, et al.Proteomic analysis of aqueous humor from primary open angle glaucoma patients on drug treatment revealed altered complement activation cascade. J Proteome Res2018;17(7):2499–2510; doi: 10.1021/acs.jproteome.8b00244
37.
NikhalashreeS, GeorgeR, ShanthaB, et al.Detection of proteins associated with extracellular matrix regulation in the aqueous humour of patients with primary glaucoma. Curr Eye Res2019;44(9):1018–1025; doi: 10.1080/02713683.2019.1608261
38.
IzzottiA, LongobardiM, CartigliaC, et al.Proteome alterations in primary open angle glaucoma aqueous humor. J Proteome Res2010;9(9):4831–4838; doi: 10.1021/pr1005372
39.
LiuH, AndersF, FunkeS, et al.Proteome alterations in aqueous humour of primary open angle glaucoma patients. Int J Ophthalmol2020;13(1):176–179; doi: 10.18240/ijo.2020.01.24
40.
FunkeS, PerumalN, BellK, et al.The potential impact of recent insights into proteomic changes associated with glaucoma. Expert Rev Proteomics2017;14(4):311–334; doi: 10.1080/14789450.2017.1298448
41.
KiełbusM, KuźmiukD, SkrzyniarzAM, et al.Changes in the protein composition of the aqueous humor in patients with glaucoma: An update review. Int J Mol Sci2025;26(7):3129; doi: 10.3390/ijms26073129
42.
KodeboyinaSK, LeeTJ, BollingerK, et al.Aqueous humor proteomic alterations associated with visual field index parameters in glaucoma patients: A pilot study. J Clin Med2021;10(6):1180; doi: 10.3390/jcm10061180
43.
HubensWHG, MohrenRJC, LiesenborghsI, et al.The aqueous humor proteome of primary open angle glaucoma: An extensive review. Exp Eye Res2020;197:108077; doi: 10.1016/j.exer.2020.108077
44.
GoldL, AyersD, BertinoJ, et al.Aptamer-Based multiplexed proteomic technology for biomarker discovery. PLoS One2010;5(12):e15004; doi: 10.1371/journal.pone.0015004
45.
BelfortRJr, MouraNC, MendesNF. T and B lymphocytes in the aqueous humor of patients with uveitis. Arch Ophthalmol1982;100(3):465–467; doi: 10.1001/archopht.1982.01030030467019
46.
MehanMR, OstroffR, WilcoxSK, et al.Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics. Adv Exp Med Biol2013;735:283–300; doi: 10.1007/978-1-4614-4118-2_20
47.
GoldL, WalkerJJ, WilcoxSK, et al.Advances in human proteomics at high scale with the SOMAscan proteomics platform. N Biotechnol2012;29(5):543–549; doi: 10.1016/j.nbt.2011.11.016
48.
ZhangJ, DuttaD, KottgenA, et al.; CKDGen Consortium. Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies. Nat Genet2022;54(5):593–602; doi: 10.1038/s41588-022-01051-w
49.
SurapaneniA, SchlosserP, ZhouL, et al.Identification of 969 protein quantitative trait loci in an African American population with kidney disease attributed to hypertension. Kidney Int2022;102(5):1167–1177; doi: 10.1016/j.kint.2022.07.005
50.
KatzDH, RobbinsJM, DengS, et al.Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods. Sci Adv2022;8(33):eabm5164; doi: 10.1126/sciadv.abm5164
51.
GudjonssonA, GudmundsdottirV, AxelssonGT, et al.A genome-wide association study of serum proteins reveals shared loci with common diseases. Nat Commun2022;13(1):480; doi: 10.1038/s41467-021-27850-z
52.
EmilssonV, GudmundsdottirV, GudjonssonA, et al.Coding and regulatory variants are associated with serum protein levels and disease. Nat Commun2022;13(1):481; doi: 10.1038/s41467-022-28081-6
53.
PietznerM, WheelerE, Carrasco-ZaniniJ, et al.Mapping the proteo-genomic convergence of human diseases. Science2021;374(6569):eabj1541; doi: 10.1126/science.abj1541
54.
FerkingstadE, SulemP, AtlasonBA, et al.Large-scale integration of the plasma proteome with genetics and disease. Nat Genet2021;53(12):1712–1721; doi: 10.1038/s41588-021-00978-w
55.
StanleyS, VanarsaK, SolimanS, et al.Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities. Nat Commun2020;11(1):2197; doi: 10.1038/s41467-020-15986-3
56.
RaffieldLM, DangH, PratteKA, et al.; NHLBI Trans-OMICS for Precision Medicine (TOPMed) Consortium. Comparison of proteomic assessment methods in multiple cohort studies. Proteomics2020;20(12):e1900278; doi: 10.1002/pmic.201900278
57.
CuvelliezM, VandewalleV, BruninM, et al.Circulating proteomic signature of early death in heart failure patients with reduced ejection fraction. Sci Rep2019;9(1):19202; doi: 10.1038/s41598-019-55727-1
58.
BodewesILA, van der SpekPJ, LeonLG, et al.Fatigue in Sjogren’s syndrome: A search for biomarkers and treatment targets. Front Immunol2019;10:312; doi: 10.3389/fimmu.2019.00312
59.
YaoC, ChenG, SongC, et al.Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease. Nat Commun2018;9(1):3268; doi: 10.1038/s41467-018-05512-x
60.
SunBB, MaranvilleJC, PetersJE, et al.Genomic atlas of the human plasma proteome. Nature2018;558(7708):73–79; doi: 10.1038/s41586-018-0175-2
61.
GiudiceV, BiancottoA, WuZ, et al.Aptamer-based proteomics of serum and plasma in acquired aplastic anemia. Exp Hematol2018;68:38–50; doi: 10.1016/j.exphem.2018.09.008
62.
ForsterK, SassS, EhrhardtH, et al.Early identification of bronchopulmonary dysplasia using novel biomarkers by proteomic screening. Am J Respir Crit Care Med2018;197(8):1076–1080; doi: 10.1164/rccm.201706-1218LE
63.
EmilssonV, IlkovM, LambJR, et al.Co-regulatory networks of human serum proteins link genetics to disease. Science2018;361(6404):769–773; doi: 10.1126/science.aaq1327
64.
SuhreK, ArnoldM, BhagwatAM, et al.Connecting genetic risk to disease end points through the human blood plasma proteome. Nat Commun2017;8:14357; doi: 10.1038/ncomms14357
65.
SasayamaD, HattoriK, OgawaS, et al.Genome-wide quantitative trait loci mapping of the human cerebrospinal fluid proteome. Hum Mol Genet2017;26(1):44–51; doi: 10.1093/hmg/ddw366
66.
CarayolJ, ChabertC, Di CaraA, et al.Protein quantitative trait locus study in obesity during weight-loss identifies a leptin regulator. Nat Commun2017;8(1):2084; doi: 10.1038/s41467-017-02182-z
67.
KauffmannA, GentlemanR, HuberW. arrayQualityMetrics–a bioconductor package for quality assessment of microarray data. Bioinformatics2009;25(3):415–416; doi: 10.1093/bioinformatics/btn647
68.
HicksSC, OkrahK, PaulsonJN, et al.Smooth quantile normalization. Biostatistics2018;19(2):185–198; doi: 10.1093/biostatistics/kxx028
69.
RitchieME, PhipsonB, WuD, et al.limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res2015;43(7):e47; doi: 10.1093/nar/gkv007
70.
AleksanderSA, BalhoffJ, CarbonS, et al.The gene ontology knowledgebase in 2023. Genetics2023;224(1); doi: 10.1093/genetics/iyad031
71.
AshburnerM, BallCA, BlakeJA, et al.Gene ontology: Tool for the unification of biology. Nat Genet2000;25(1):25–29; doi: 10.1038/75556
LiberzonA, BirgerC, ThorvaldsdóttirH, et al.The molecular signatures database hallmark Gene Set Collection. Cell Syst2015;1(6):417–425; doi: 10.1016/j.cels.2015.12.004
74.
FriedmanJ, HastieT, TibshiraniR. Regularization paths for generalized linear models via coordinate descent. J Stat Softw2010;33(1):1–22; doi: 10.18637/jss.v033.i01
75.
TayJK, NarasimhanB, HastieT. Elastic net regularization paths for all generalized linear models. J Stat Softw2023;106(1):1; doi: 10.18637/jss.v106.i01
76.
LinJB, PittsKM, El HelweH, et al.Neurofilament light chain in aqueous humor as a marker of neurodegeneration in glaucoma. Clin Ophthalmol2023;17:2209–2217; doi: 10.2147/opth.s417664
77.
KaeserSA, LehallierB, ThinggaardM, et al.A neuronal blood marker is associated with mortality in old age. Nat Aging2021;1(2):218–225; doi: 10.1038/s43587-021-00028-4
78.
SasakiY, EngberTM, HughesRO, et al.cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons. Exp Neurol2020;329:113252; doi: 10.1016/j.expneurol.2020.113252
79.
BakaP, SteenkenL, Escolano-LozanoF, et al.Studying serum neurofilament light chain levels as a potential new biomarker for small fiber neuropathy. Eur J Neurol2024;31(4):e16192; doi: 10.1111/ene.16192
80.
FissoloN, BenkertP, Sastre-GarrigaJ, et al.Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry2024;95(5):410–418; doi: 10.1136/jnnp-2023-332251
81.
FrankA, BendigJ, SchnalkeN, et al.Serum neurofilament indicates accelerated neurodegeneration and predicts mortality in late-stage Parkinson’s disease. NPJ Parkinsons Dis2024;10(1):14; doi: 10.1038/s41531-023-00605-x
82.
FranthalS, KhalilM, KernD, et al.Elevated serum neurofilament light chain protein in patients with essential tremor. Eur J Neurol2024;31(2):e16143; doi: 10.1111/ene.16143
83.
NovobilskyR, BartovaP, LichaK, et al.Serum neurofilament light chain levels in patients with cognitive deficits and movement disorders: Comparison of cerebrospinal and serum neurofilament light chain levels with other biomarkers. Front Hum Neurosci2023;17:1284416; doi: 10.3389/fnhum.2023.1284416
84.
SanoT, MasudaY, YasunoH, et al.Plasma neurofilament light chain as a potential biomarker of neurodegeneration in murine brain. Toxicol Res (Camb)2023;12(5):751–755; doi: 10.1093/toxres/tfad063
85.
YangY, KimWS, MichaelianJC, et al.Predicting neurodegeneration from sleep related biofluid changes. Neurobiol Dis2024;190:106369; doi: 10.1016/j.nbd.2023.106369
86.
SeamanMNJ. Membrane traffic in the secretory pathway. Cell Mol Life Sci2008;65(18):2842–2858; doi: 10.1007/s00018-008-8354-1
87.
Vazquez-SanchezS, Gonzalez-LozanoMA, WalfenzaoA, et al.The endosomal protein sorting nexin 4 is a synaptic protein. Sci Rep2020;10(1):18239; doi: 10.1038/s41598-020-74694-6
88.
HenkelV, SchürmannsL, BrunnerM, et al.Role of sorting nexin PaATG24 in autophagy, aging and development of Podospora anserina. Mech Ageing Dev2020;186:111211; doi: 10.1016/j.mad.2020.111211
89.
DadaT, VermaS, GagraniM, et al.Ocular and systemic factors associated with glaucoma. J Curr Glaucoma Pract2022;16(3):179–191; doi: 10.5005/jp-journals-10078-1383
SalimS, ShieldsMB. Glaucoma and systemic diseases. Surv Ophthalmol2010;55(1):64–77; doi: 10.1016/j.survophthal.2009.03.006
92.
PacheM, FlammerJ. A sick eye in a sick body? Systemic findings in patients with primary open-angle glaucoma. Surv Ophthalmol2006;51(3):179–212; doi: 10.1016/j.survophthal.2006.02.008
93.
NucciC, MartucciA, CesareoM, et al.Links among glaucoma, neurodegenerative, and vascular diseases of the central nervous system. In: Elsevier: 2015; pp. 49–65.
94.
Coca-PradosM, EscribanoJ. New perspectives in aqueous humor secretion and in glaucoma: The ciliary body as a multifunctional neuroendocrine gland. Prog Retin Eye Res2007;26(3):239–262; doi: 10.1016/j.preteyeres.2007.01.002
95.
AulerN, TonnerH, PfeifferN, et al.Antibody and protein profiles in glaucoma: Screening of biomarkers and identification of signaling pathways. Biology (Basel)2021;10(12):1296; doi: 10.3390/biology10121296
96.
SamelskaK, Zaleska-ŻmijewskaA, BałanB, et al.Immunological and molecular basics of the primary open angle glaucoma pathomechanism. Cent Eur J Immunol2021;46(1):111–117; doi: 10.5114/ceji.2021.104328
97.
VernazzaS, OddoneF, TirendiS, et al.Risk factors for retinal ganglion cell distress in glaucoma and neuroprotective potential intervention. Int J Mol Sci2021;22(15):7994; doi: 10.3390/ijms22157994
98.
KodeboyinaSK, LeeTJ, ChurchwellL, et al.The constitutive proteome of human aqueous humor and race specific alterations. Proteomes2020;8(4):34; doi: 10.3390/proteomes8040034
99.
BeutgenVM, PerumalN, PfeifferN, et al.Autoantibody Biomarker Discovery in Primary Open Angle Glaucoma Using Serological Proteome Analysis (SERPA). Front Immunol2019;10:381; doi: 10.3389/fimmu.2019.00381
100.
WilliamsE, AltmanJ, AhmedS, et al.Unveiling the levels and significance of different serpin family proteins in aqueous humor dynamics. BMC Ophthalmol2025;25(1):297; doi: 10.1186/s12886-025-04119-3
101.
De MariaA, ZientekKD, DavidLL, et al.Compositional analysis of extracellular aggregates in the eyes of patients with exfoliation syndrome and exfoliation glaucoma. Invest Ophthalmol Vis Sci2021;62(15):27; doi: 10.1167/iovs.62.15.27
102.
MäättäM, HeljasvaaraR, PihlajaniemiT, et al.Collagen XVIII/endostatin shows a ubiquitous distribution in human ocular tissues and endostatin-containing fragments accumulate in ocular fluid samples. Graefes Arch Clin Exp Ophthalmol2007;245(1):74–81; doi: 10.1007/s00417-006-0281-y
103.
HaddadinRI, OhDJ, KangMH, et al.Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures. Invest Ophthalmol Vis Sci2012;53(10):6708–6717; doi: 10.1167/iovs.11-9013
104.
ShanS-W, DoC-W, LamTC, et al.Thrombospondin-1 mediates Rho-kinase inhibitor-induced increase in outflow-facility. J Cell Physiol2021;236(12):8226–8238; doi: 10.1002/jcp.30492
105.
WirtzMK, SykesR, SamplesJ, et al.Identification of missense extracellular matrix gene variants in a large glaucoma pedigree and investigation of the N700S Thrombospondin-1 variant in normal and glaucomatous trabecular meshwork cells. Curr Eye Res2022;47(1):79–90; doi: 10.1080/02713683.2021.1945109
106.
GoyanesAM, MoldobaevaA, MarimoutouM, et al.Functional impact of human genetic variants of COL18A1/Endostatin on pulmonary endothelium. Am J Respir Cell Mol Biol2020;62(4):524–534; doi: 10.1165/rcmb.2019-0056oc
107.
ZhangZ, LiuX, ShenZ, et al.Endostatin in fibrosis and as a potential candidate of anti-fibrotic therapy. Drug Deliv2021;28(1):2051–2061; doi: 10.1080/10717544.2021.1983071
108.
YoungTL, WhisenhuntKN, JinJ, et al.SVEP1 as a genetic modifier of TEK-Related primary congenital glaucoma. Invest Ophthalmol Vis Sci2020;61(12):6; doi: 10.1167/iovs.61.12.6
109.
HußmannM, SchulteD, WeischerS, et al.Svep1 is a binding ligand of Tie1 and affects specific aspects of facial lymphatic development in a Vegfc-independent manner. Elife2023;12:e82969; doi: 10.7554/eLife.82969
110.
KizhatilK, RyanM, MarchantJK, et al.Schlemm’s canal is a unique vessel with a combination of blood vascular and lymphatic phenotypes that forms by a novel developmental process. PLoS Biol2014;12(7):e1001912; doi: 10.1371/journal.pbio.1001912
111.
GharahkhaniP, JorgensonE, HysiP, et al.; 23 and Me Research Team. Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries. Nat Commun2021;12(1):1258; doi: 10.1038/s41467-020-20851-4
112.
LangheRP, GudzenkoT, BachmannM, et al.Cadherin-11 localizes to focal adhesions and promotes cell-substrate adhesion. Nat Commun2016;7:10909; doi: 10.1038/ncomms10909
113.
SchneiderDJ, WuM, LeTT, et al.Cadherin‐11 contributes to pulmonary fibrosis: Potential role in TGF‐β production and epithelial to mesenchymal transition. Faseb J2012;26(2):503–512; doi: 10.1096/fj.11-186098
114.
PassanhaFR, DivinagraciaML, LapointeVLS. Cadherin-11 regulates cell proliferation via the PDGFRβ-ERK1/2 signaling pathway in human mesenchymal stem cells. Stem Cells2022;40(2):165–174; doi: 10.1093/stmcls/sxab019
115.
PassanhaFR, GeuensT, LaPointeVLS. Cadherin-11 influences differentiation in human mesenchymal stem cells by regulating the extracellular matrix Via the TGFβ1 pathway. Stem Cells2022;40(7):669–677; doi: 10.1093/stmcls/sxac026
116.
LodygaM, CambridgeE, KarvonenHM, et al.Cadherin-11–mediated adhesion of macrophages to myofibroblasts establishes a profibrotic niche of active TGF-β. Sci Signal2019;12(564):eaao3469; doi: 10.1126/scisignal.aao3469
117.
WirtzMK, BradleyJMB, XuH, et al.Proteoglycan expression by human trabecular meshworks. Curr Eye Res1997;16(5):412–421; doi: 10.1076/ceyr.16.5.412.7040
118.
PintoF, Santos-FerreiraL, PintoM, et al.The extracellular small leucine-rich proteoglycan biglycan is a key player in gastric cancer aggressiveness. Cancers (Basel)2021;13(6):1330; doi: 10.3390/cancers13061330
119.
SchulzM, DiehlV, TrebickaJ, et al.Biglycan: A regulator of hepatorenal inflammation and autophagy. Matrix Biol2021;100–101:150–161; doi: 10.1016/j.matbio.2021.06.001
120.
PoluzziC, NastaseMV, Zeng-BrouwersJ, et al.Biglycan evokes autophagy in macrophages via a novel CD44/Toll-like receptor 4 signaling axis in ischemia/reperfusion injury. Kidney Int2019;95(3):540–562; doi: 10.1016/j.kint.2018.10.037
121.
KurodaYT, KomamuraK, TatsumiR, et al.Vascular cell adhesion molecule-1 as a biochemical marker of left ventricular mass in the patients with hypertension. Am J Hypertens2001;14(9 Pt 1):868–872; doi: 10.1016/s0895-7061(01)02139-2
122.
TroncosoMF, Ortiz-QuinteroJ, Garrido-MorenoV, et al.VCAM-1 as a predictor biomarker in cardiovascular disease. Biochim Biophys Acta Mol Basis Dis2021;1867(9):166170; doi: 10.1016/j.bbadis.2021.166170
123.
PapayianniA, AlexopoulosE, GiamalisP, et al.Circulating levels of ICAM‐1, VCAM‐1, and MCP‐1 are increased in haemodialysis patients: Association with inflammation, dyslipidaemia, and vascular events. Nephrol Dial Transplant2002;17(3):435–441; doi: 10.1093/ndt/17.3.435
124.
BoardmanR, PangV, MalhiN, et al.Activation of Notch signaling by soluble Dll4 decreases vascular permeability via a cAMP/PKA-dependent pathway. Am J Physiol Heart Circ Physiol2019;316(5):H1065–H1075; doi: 10.1152/ajpheart.00610.2018
125.
ScehnetJS, JiangW, KumarSR, et al.Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood2007;109(11):4753–4760; doi: 10.1182/blood-2006-12-063933
126.
LobovIB, RenardRA, PapadopoulosN, et al.Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci U S A2007;104(9):3219–3224; doi: 10.1073/pnas.0611206104
127.
CameloS, RaoulW, LavaletteS, et al.Delta-like 4 inhibits choroidal neovascularization despite opposing effects on vascular endothelium and macrophages. Angiogenesis2012;15(4):609–622; doi: 10.1007/s10456-012-9290-0
128.
DhamodaranK, BaidouriH, NarteyA, et al.Endogenous expression of Notch pathway molecules in human trabecular meshwork cells. Exp Eye Res2022;216:108935; doi: 10.1016/j.exer.2022.108935
129.
KhalilM, PirpamerL, HoferE, et al.Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat Commun2020;11(1):812; doi: 10.1038/s41467-020-14612-6
130.
TaniguchiT, ShimazawaM, HaraH. Alterations in neurofilament light in optic nerve in rat kainate and monkey ocular hypertension models. Brain Res2004;1013(2):241–248; doi: 10.1016/j.brainres.2004.04.023
131.
MarkakiI, BergströmS, TsitsiP, et al.Cerebrospinal fluid levels of Kininogen‐1 indicate early cognitive impairment in Parkinson’s disease. Mov Disord2020;35(11):2101–2106; doi: 10.1002/mds.28192
132.
LiuY, CaoDJ, SainzIM, et al.The inhibitory effect of HKa in endothelial cell tube formation is mediated by disrupting the uPA-uPAR complex and inhibiting its signaling and internalization. Am J Physiol Cell Physiol2008;295(1):C257–C67; doi: 10.1152/ajpcell.00569.2007
133.
SharifNA, KatoliP, ScottD, et al.FR-190997, a Nonpeptide Bradykinin B2-receptor partial agonist, is a potent and efficacious intraocular pressure lowering agent in ocular hypertensive cynomolgus monkeys. Drug Dev Res2014;75(4):211–223; doi: 10.1002/ddr.21174
134.
SharifNA, LiL, KatoliP, et al.Preclinical pharmacology, ocular tolerability and ocular hypotensive efficacy of a novel non-peptide bradykinin mimetic small molecule. Exp Eye Res2014;128(0):170–180; doi: 10.1016/j.exer.2014.10.008
135.
SharifNA, WangY, KatoliP, et al.Human non-pigmented ciliary epithelium bradykinin B2-receptors: Receptor localization, pharmacological characterization of intracellular Ca2+ mobilization, and prostaglandin secretion. Curr Eye Res2014;39(4):378–389; doi: 10.3109/02713683.2013.816324
136.
SharifNA, XuSX. Pharmacological characterization of bradykinin receptors coupled to phosphoinositide turnover in SV40-Immortalized human trabecular meshwork cells. Exp Eye Res1996;63(6):631–637; doi: 10.1006/exer.1996.0157
137.
WebbJG, ShearerTW, YatesPW, et al.Bradykinin enhancement of PGE2 signalling in bovine trabecular meshwork cells. Exp Eye Res2003;76(3):283–289; doi: 10.1016/S0014-4835(02)00313-5
138.
WebbJG, YangX, CrossonCE. Expression of the kallikrein/kinin system in human anterior segment. Exp Eye Res2009;89(2):126–132; doi: 10.1016/j.exer.2009.02.016
139.
VashishthaA, MainaSW, AltmanJ, et al.Complement system proteins in the human aqueous humor and their association with primary open-angle glaucoma. J Pers Med2023;13(9):1400; doi: 10.3390/jpm13091400
140.
KimJ-H, AfridiR, HanJ, et al.Gamma subunit of complement component 8 is a neuroinflammation inhibitor. Brain2021;144(2):528–552; doi: 10.1093/brain/awaa425
141.
PatelPA, LeeTJ, KodeboyinaSK, et al.Intra-population differences of apolipoproteins in the aqueous humor. Lipids Health Dis2021;20(1):128; doi: 10.1186/s12944-021-01555-0
142.
GharahkhaniP, BurdonKP, FogartyR, et al.; Wellcome Trust Case Control Consortium 2, NEIGHBORHOOD consortium. Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma. Nat Genet2014;46(10):1120–1125; doi: 10.1038/ng.3079
143.
StewartWC, SineC, SutherlandS, et al.Total cholesterol and high-density lipoprotein levels as risk factors for increased intraocular pressure. Am J Ophthalmol1996;122(4):575–577; doi: 10.1016/s0002-9394(14)72121-x
144.
SturM, GrabnerG, DordaW, et al.The effect of timolol on the concentrations of albumin and IgG in the aqueous humor of the human eye. Am J Ophthalmol1983;96(6):726–729; doi: 10.1016/s0002-9394(14)71914-2
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
